[go: up one dir, main page]

PE20070713A1 - 4-amino-5-cloro-n-{[1-(tetrahidro-2h-piran-4-ilmetil)-4-piperidinil]metil}-1-benzofuran-7-carboxamida en el tratamiento de alzheimer - Google Patents

4-amino-5-cloro-n-{[1-(tetrahidro-2h-piran-4-ilmetil)-4-piperidinil]metil}-1-benzofuran-7-carboxamida en el tratamiento de alzheimer

Info

Publication number
PE20070713A1
PE20070713A1 PE2006001310A PE2006001310A PE20070713A1 PE 20070713 A1 PE20070713 A1 PE 20070713A1 PE 2006001310 A PE2006001310 A PE 2006001310A PE 2006001310 A PE2006001310 A PE 2006001310A PE 20070713 A1 PE20070713 A1 PE 20070713A1
Authority
PE
Peru
Prior art keywords
benzofuran
pyran
carboxamide
tetrahydro
chloro
Prior art date
Application number
PE2006001310A
Other languages
English (en)
Inventor
Mohammed Mahmood Ahmed
Neil Derek Miller
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0522071A external-priority patent/GB0522071D0/en
Priority claimed from GB0619950A external-priority patent/GB0619950D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20070713A1 publication Critical patent/PE20070713A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE 4-AMINO-5-CLORO-N-{[1-(TETRAHIDRO-2H-PIRAN-4-ILMETIL)-4-PIPERIDINIL]METIL}-1-BENZOFURAN-7-CARBOXAMIDA Y SUS SALES DE TOSILATO, TOSILATO MONOHIDRATO, TOSILATO ANHIDRO. REFERIDA TAMBIEN A UN PROCEDIMIENTO DE PREPARACION QUE COMPRENDE: A) REACCIONAR 4-AMINO-5-CLORO-N-(4-PIPERIDINILMETIL)-1-BENZOFURAN-7-CARBOXAMIDA O UNA SAL O DERIVADO PROTEGIDO DE LA MISMA CON TETRAHIDRO-2H-PIRAN-4-CARBALDEHIDO; B) DESPROTEGER EL COMPUESTO; C) FORMAR LA SAL FARMACEUTICA. DICHOS COMPUESTOS SON AGONISTAS DEL RECEPTOR 5-HT4, UTILES EN EL TRATAMIENTO DE ALZHEIMER
PE2006001310A 2005-10-28 2006-10-26 4-amino-5-cloro-n-{[1-(tetrahidro-2h-piran-4-ilmetil)-4-piperidinil]metil}-1-benzofuran-7-carboxamida en el tratamiento de alzheimer PE20070713A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0522071A GB0522071D0 (en) 2005-10-28 2005-10-28 Novel compound
GB0619950A GB0619950D0 (en) 2006-10-09 2006-10-09 Novel compounds

Publications (1)

Publication Number Publication Date
PE20070713A1 true PE20070713A1 (es) 2007-09-27

Family

ID=37591731

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006001310A PE20070713A1 (es) 2005-10-28 2006-10-26 4-amino-5-cloro-n-{[1-(tetrahidro-2h-piran-4-ilmetil)-4-piperidinil]metil}-1-benzofuran-7-carboxamida en el tratamiento de alzheimer

Country Status (4)

Country Link
AR (1) AR056729A1 (es)
PE (1) PE20070713A1 (es)
TW (1) TW200732327A (es)
WO (1) WO2007048643A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102762572A (zh) 2010-02-01 2012-10-31 诺瓦提斯公司 作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物
WO2011092293A2 (en) 2010-02-01 2011-08-04 Novartis Ag Cyclohexyl amide derivatives as crf receptor antagonists
US8835444B2 (en) 2010-02-02 2014-09-16 Novartis Ag Cyclohexyl amide derivatives as CRF receptor antagonists
CN107406434B (zh) 2015-02-13 2020-09-11 苏文生命科学有限公司 作为5-ht4受体激动剂的酰胺化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0820586A (ja) * 1994-07-05 1996-01-23 Sanwa Kagaku Kenkyusho Co Ltd １−アザビシクロ［３．３．０］オクタン誘導体、その塩及び製法並びに用途
WO2005092882A1 (en) * 2004-03-01 2005-10-06 Pfizer Japan, Inc. 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders

Also Published As

Publication number Publication date
WO2007048643A1 (en) 2007-05-03
TW200732327A (en) 2007-09-01
AR056729A1 (es) 2007-10-17

Similar Documents

Publication Publication Date Title
HN2010002491A (es) Derivados de quinolinas y quinoxalinas como inhibidores de cinasa de proteina tirosina
BRPI0821004A8 (pt) Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste
CL2009000394A1 (es) Compuestos derivados de n-(1h-indazol-5-il)pirrolidin-3-carboxamida sustituida, inhibidores de erk; composicion farmaceutica; y su uso en el tratamiento del cancer.
CY1116118T1 (el) Κρυσταλλικες μορφες (r)-5-[3-χλωρο-4-(2,3-διυδροξυ-προποξυ)-βενζ[ζ]υλιδενιο]-2-([ζ]-προπυλιμινο)-3-o-τομυλ-θειαζολιδιν-4-ονης
UA110207C2 (xx) ФАРМАЦЕВТИЧНА ТАБЛЕТКА, ЯКА МІСТИТЬ 1-(β-D-ГЛЮКОПІРАНОЗИЛ)-4-МЕТИЛ-3-$5-(4-ФТОРФЕНІЛ)-2-ТІЄНІЛМЕТИЛ]БЕНЗОЛ ЯК ІНГІБІТОР НАТРІЙЗАЛЕЖНОГО ПЕРЕНОСНИКА ГЛЮКОЗИ (НЗПГ)
UY30310A1 (es) Derivados 2-azetidinona, sales, solvatos, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
BRPI0716598A2 (pt) Derivados de (hetero) arilsulfonamida de n-biarila úteis no tratamento de doenças medidas por interações de linfócitos
CY1109072T1 (el) Βητα κρυσταλλικη μορφη του υδροχλωρικου αλατος της ιβαμπραδινης, μεθοδος παρασκευης αυτου και φαρμακευτικης συνθεσεις που το περιεχουν
CO6331340A2 (es) Pirrolo-pirimidinas y pirrolo piridinas
BRPI0507617A (pt) antagonistas de receptor de quimiocina
BR112012027743A2 (pt) ciclopropil dicarboxamidas e análogos exibindo atividades anticâncer e antiproliferativas
ECSP088974A (es) Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3)
NO20074295L (no) Substituerte gamma lactamer som terapeutiske midler
CL2009000923A1 (es) Compuestos derivados de 1-(aminoacetil)-n-(1-cicloalquil)pirrolidina-2-carboxamida sustituidas; composicion farmaceutica; utiles para tratar la hepatitis c.
NI201200059A (es) PIPERIDINAS SUSTITUIDAS QUE AUMENTAN LA ACTIVIDAD DE p53 Y SUS USOS
MX2009011579A (es) Pirimidinonas como moduladores de caseina cinasa ii (ck2).
CL2009000906A1 (es) Compuestos derivados de 4-imidazolil y 4-triazolil de 2-(6-(4-cicloalquilpiperazin-1-il)pirimidin-4-il)-1h-pirazol-3(2h)ona inhibidores de hif-prolil-4-hidroxilasas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de enfermedades cardiovasculares, renales y hematologicas.
CO6480931A2 (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas.
AR054425A1 (es) Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
DK1942868T4 (da) Natriumchloridopløsning til lægemiddel-rekonstitution eller -fortynding
NZ630488A (en) Piperidine derivatives for gpr119 agonist
NO20090779L (no) 5,6-bisaryl-2-pyridin-karboksamidderivater, fremstilling og anvendelse derav i terapeutika som uretosin II receptorantagonister
MX372721B (es) Ánalogos halogenados de agentes antifi-broticos.
DE602007012313D1 (de) Als a2b-adenosinrezeptorantagonisten geeignete 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoä4,5-büpyridin-2-onderivate
PE20150607A1 (es) Composicion farmaceutica que comprende fimasartan e hidroclorotiazida

Legal Events

Date Code Title Description
FC Refusal